by The global prostate cancer market size was approximate at US$ 12.07 billion in 2022 and is anticipated to grow US$ 28.37 billion by 2032, registering a compound annual growth rate of 8.92% from 2023 to 2032.
The prostate cancer market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the prostate cancer market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the prostate cancer report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the prostate cancer market have been studied and analysed across many developments.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2964
Prostate Cancer Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 13.15 Billion |
| Market Size by 2032 | USD 28.37 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.92% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Drug Class and By Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Also read: Life Science Chemical and Instrumentation Market Size to Grow US$ 103.29 Billion By 2032
Research Approach
The comprehensive report on the global prostate cancer market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global prostate cancer market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- AbbVie, Inc.
- Astellas Pharma, Inc.
- AstraZeneca plc
- Bayer AG
- Clovis Oncology, Inc.
- Dendreon Pharmaceuticals LLC
- Ferring Pharmaceuticals
- Johnson & Johnson (Janssen)
- Merck & Co., Inc.
- Pfizer, Inc.
- Sanofi S.A.
Prostate Cancer Market Segmentations
By Drug Class
- Hormonal ADT
- AR-Directed Therapies
- Cytotoxic agents
- Bone metastases
- therapeutic vaccines
- PARP inhibitors
- Kinase inhibitors
- PSMA-targeted radioligands
By Distribution Channel
- Hospital Pharmacies
- Drug store & Retail pharmacies
- Online pharmacies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Prostate Cancer Market
5.1. COVID-19 Landscape: Prostate Cancer Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Prostate Cancer Market, By Drug Class
8.1. Prostate Cancer Market Revenue and Volume, by Drug Class, 2023-2032
8.1.1. Hormonal ADT
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. AR-Directed Therapies
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Cytotoxic agents
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Bone metastases
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
8.1.5. therapeutic vaccines
8.1.5.1. Market Revenue and Volume Forecast (2020-2032)
8.1.6. PARP inhibitors
8.1.6.1. Market Revenue and Volume Forecast (2020-2032)
8.1.7. Kinase inhibitors
8.1.7.1. Market Revenue and Volume Forecast (2020-2032)
8.1.8. PSMA-targeted radioligands
8.1.8.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Prostate Cancer Market, By Distribution Channel
9.1. Prostate Cancer Market Revenue and Volume, by Distribution Channel, 2023-2032
9.1.1. Hospital Pharmacies
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Drug store & Retail pharmacies
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Online pharmacies
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Prostate Cancer Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.1.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.2.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.3.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.4.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.5.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Drug Class (2020-2032)
10.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
Chapter 11. Company Profiles
11.1. AbbVie, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Astellas Pharma, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. AstraZeneca p
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Clovis Oncology, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Dendreon Pharmaceuticals LLC
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Ferring Pharmaceuticals
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Johnson & Johnson (Janssen)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Merck & Co., Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Pfizer, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global prostate cancer market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for prostate cancer are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
